Cytovale

Cytovale Providing rapid and insightful ways to diagnose fast-moving and immune-mediated diseases.

The hardest sepsis decisions don't happen when you know it's sepsis. They happen in the first 60 minutes, when the diffe...
06/24/2026

The hardest sepsis decisions don't happen when you know it's sepsis. They happen in the first 60 minutes, when the differential diagnosis is wide, the labs aren't back yet, and you're already committing to a treatment path.

Most sepsis tools are built to confirm suspicion. But confirmation isn't the bottleneck. Confidence and speed are. Having a signal you trust, early enough to act on it.
IntelliSep returns an objective sepsis risk score in 10 minutes or less from a standard blood draw. Not to replace judgment, but to give physicians concrete information before cultures, lactate trends, or the broader clinical trajectory have had time to tell the story.
Earlier signal. More confident decisions. Within the first hour.

đź”— https://na2.hubs.ly/H06hHJl0

06/24/2026

In sepsis care, two patients can initially appear very similar and follow completely different clinical paths.

In this webinar clip, physicians from Froedtert & the Medical College of Wisconsin discuss why predicting deterioration early in sepsis remains such a major challenge in emergency medicine, and how host response diagnostics may help identify patients at higher risk earlier in their ED journey.

Webinar: How a Novel Sepsis Diagnostic Enables Life-Saving Decisions: New Real-World Evidence
Speakers:
• Thomas Carver, MD, FACS
• Nathan Ledeboer, PhD

Watch the full webinar: https://na2.hubs.ly/H05P9jW0

06/18/2026

In this webinar clip, physicians from Froedtert & the Medical College of Wisconsin discuss real-world outcomes observed after implementing IntelliSep in ED patients with suspected infection.

The discussion covers observed reductions in mortality and hospital length of stay, along with the operational impact earlier sepsis risk assessment may have on patient management and throughput.

Webinar: How a Novel Sepsis Diagnostic Enables Life-Saving Decisions: New Real-World Evidence

Watch the full webinar: https://na2.hubs.ly/H05P8B30

Cytovale is proud to support the Unite for Sepsis Symposium on June 11-12, 2026 in Washington, DC. It’s more than a symp...
06/10/2026

Cytovale is proud to support the Unite for Sepsis Symposium on June 11-12, 2026 in Washington, DC. It’s more than a symposium—it’s a collaborative movement to improve prevention, diagnosis, and treatment of sepsis, and ultimately save lives and limbs.

Learn more and register at https://na2.hubs.ly/H061ccD0.

06/09/2026

Sepsis diagnosis is rarely straightforward. In this webinar clip, physicians from Froedtert & the Medical College of Wisconsin discuss a Delphi analysis where clinicians reviewed the same patient cases and often reached very different conclusions about sepsis risk.

The discussion highlights a major challenge in emergency medicine: early sepsis symptoms are often nonspecific, and clinical judgment alone can vary widely between providers.

Watch the full webinar: https://na2.hubs.ly/H05P8Mf0

Webinar: How a Novel Sepsis Diagnostic Enables Life-Saving Decisions: New Real-World Evidence

Speakers:
• Thomas Carver, MD, FACS
• Nathan Ledeboer, PhD

A 24% reduction in mortality. Nearly 30,000 hospital days saved.In a recent 's Hospital Review article, FMOL Health repo...
06/04/2026

A 24% reduction in mortality. Nearly 30,000 hospital days saved.

In a recent 's Hospital Review article, FMOL Health reported these outcomes after implementing IntelliSep across its health system.

FMOL estimates that IntelliSep has saved roughly 30,000 hospital days over the past two years, equivalent to the capacity of an 85-bed facility.

The article highlights how earlier sepsis assessment can impact not only patient outcomes, but also hospital capacity, throughput, and resource utilization.

Read the Becker's article:
https://na2.hubs.ly/H05XLlV0

06/02/2026

In sepsis care, two patients can initially appear very similar and follow completely different clinical paths.

In this webinar clip, physicians from Froedtert & the Medical College of Wisconsin discuss why predicting deterioration early in sepsis remains such a major challenge in emergency medicine, and how host response diagnostics may help identify patients at higher risk earlier in their ED journey.

Webinar: How a Novel Sepsis Diagnostic Enables Life-Saving Decisions: New Real-World Evidence

Speakers:
• Thomas Carver, MD, FACS
• Nathan Ledeboer, PhD

Watch the full webinar: https://na2.hubs.ly/H05P5vP0

medicine

Hear how sepsis risk is evolving from a compliance task to a strategic operational and financial consideration. Watch th...
05/28/2026

Hear how sepsis risk is evolving from a compliance task to a strategic operational and financial consideration. Watch the full webinar hosted by Becker's Healthcare, featuring insights from clinical leaders.

You’ll hear:
✔️️ Where outdated SEP-1 strategies create operational strain
✔️ Why early ED risk assessment, including host-response insights, matters more than ever
✔️ What’s coming next in federal sepsis quality measures

Watch now:
https://na2.hubs.ly/H05KDRB0

In this episode of the Straight from the Source podcast, Christopher Thomas, MD and Hollis “Bud” O’Neal, MD, share how F...
05/27/2026

In this episode of the Straight from the Source podcast, Christopher Thomas, MD and Hollis “Bud” O’Neal, MD, share how FMOL Health became an early partner with Cytovale and what it actually took to implement IntelliSep across a health system.

Not just introducing a new test, but aligning clinical teams, operations, IT, workflows, and leadership around earlier sepsis decision-making in the ED.

They also discuss the real-world outcomes observed alongside implementation, including differences in mortality, length of stay, and antibiotic utilization.

This isn’t a story about adopting new technology. It’s a story about what it takes to move sepsis improvement efforts beyond pilot programs and into everyday practice.

🎧 https://na2.hubs.ly/H05KF0t0

Security is foundational to how we handle clinical data.Cytovale has achieved SOC 2 Type II attestation under the Securi...
05/18/2026

Security is foundational to how we handle clinical data.

Cytovale has achieved SOC 2 Type II attestation under the Security Trust Services Criteria supporting controls related to data security, availability, and confidentiality.

Designed for critical clinical environments where trust and data protection are non-negotiable.

Learn more: https://na2.hubs.ly/H05rwGm0

Address

2 Tower Place
South San Francisco, CA
94080

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+14154172188

Website

Alerts

Be the first to know and let us send you an email when Cytovale posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Cytovale:

Shortcuts

Share

Category